25-7-2025 – Wellgistics Health (NASDAQ: WGRX), a leading health-tech firm, has filed an S-1 form with the SEC, outlining plans to deepen its use of XRP and the XRP Ledger (XRPL) for real-time payment solutions. The company aims to streamline transactions across its network of over 6,000 pharmacies and 150 manufacturers, leveraging XRP’s low-cost, near-instant settlement capabilities.
The Florida-based pharmaceutical distributor secured a $50 million equity line of credit from LDA Capital to fund its XRP strategy, which includes holding XRP as a treasury reserve, using it as collateral, and generating income from its holdings. CEO Brian Norton emphasized the move as a shift toward efficient, blockchain-driven infrastructure, stating that future healthcare leaders will prioritize “fast rails” and transparency over outdated systems. Ripple attorney Bill Morgan highlighted the filing as a strong example of XRPL’s business utility, noting Wellgistics’ multifaceted approach to XRP adoption.
However, the S-1 filing acknowledges risks, including regulatory uncertainty from the ongoing Ripple-SEC lawsuit, which could affect XRP’s value. Despite this, Wellgistics is among a growing number of public companies, like Nature’s Miracle, embracing XRP for institutional use.
The company plans to issue securities to acquire more tokens, signaling confidence in XRP’s role in transforming healthcare payments.
